In Vitro Effect of α-Tocopherol, Ascorbic Acid and Lycopene on Low Density Lipoprotein Glycation

authors:

avatar Mohammad Ali Ghaffari 1 , * , avatar Samad Mojab 1

Department of Clinical Biochemistry, School of Medicine, Ahwaz Jundishapour University of Medical Sciences, Ahwaz, Iran

how to cite: Ghaffari M A, Mojab S. In Vitro Effect of α-Tocopherol, Ascorbic Acid and Lycopene on Low Density Lipoprotein Glycation. Iran J Pharm Res. 2007;6(4):e128342. https://doi.org/10.22037/ijpr.2010.731.

Abstract

Nonenzymatic glycation of low density lipoprotein (LDL) is a reaction of glucose and other reducing sugars with apolipoprotein B100 (apo-B100) lysine residues. In diabetes, this reaction is greatly accelerated and is important in the pathogenesis of diabetic complications. The objective of this study was to investigate in vitro effects of α-tocopherol, ascorbic acid and lycopene on LDL glycation.
 
 
LDL was isolated from EDTA-plasma by ultracentrifugation using a single step discontinuous gradient. LDL and glucose were incubated without and with different concentrations of lycopene, ascorbic acid and α-tocopherol. LDL glycation were estimated by sodium periodate assay.
 
 
Based on this study results, α-tocopherol, ascorbic acid and lycopene decrease LDL glycation in a dose dependent manner. The electrophoretic mobility of glycated LDL decreased in presence these nutrients.
 
 
These effects may be due to antioxidant properties of these nutrients and may have a role in ameliorating atherosclerotic risk of patients with diabetes mellitus.